Crane Co
For the period ended Sep 30, 2025. Filed Oct 29, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 29, 2025
CR$210.20+4.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| (in millions) | September 30,2025 | December 31,2024 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $388.2 | $306.7 |
| Accounts receivable, net of allowance for doubtful accounts of $8.1 as of September 30, 2025 and $8.7 as of December 31, 2024 | 387.9 | 339.1 |
| Inventories, net: | ||
| Finished goods | 68.2 | 64.2 |
| Finished parts and subassemblies | 50.3 | 50.7 |
| Work in process | 58.0 | 51.4 |
| Raw materials | 218.2 | 214.1 |
| Inventories, net | 394.7 | 380.4 |
| Other current assets | 109.5 | 159.1 |
| Current assets held for sale | — | 217.9 |
| Total current assets | 1,280.3 | 1,403.2 |
| Property, plant and equipment: | ||
| Cost | 737.8 | 682.9 |
| Less: accumulated depreciation | 459.4 | 421.6 |
| Property, plant and equipment, net | 278.4 | 261.3 |
| Long-term deferred tax assets | 6.1 | 11.2 |
| Other assets | 147.4 | 144.7 |
| Intangible assets, net | 152.7 | 159.9 |
| Goodwill | 684.1 | 661.6 |
| Total assets | $2,549.0 | $2,641.9 |
CONDENSED CONSOLIDATED BALANCE SHEETS
| (in millions, except per share and share data) | September 30,2025 | December 31,2024 |
|---|---|---|
| Liabilities and equity | ||
| Current liabilities: | ||
| Accounts payable | $149.5 | $188.2 |
| Accrued liabilities | 231.1 | 303.2 |
| U.S. and foreign taxes on income | 11.4 | 7.9 |
| Current liabilities held for sale | — | 44.1 |
| Total current liabilities | 392.0 | 543.4 |
| Long-term debt, net | — | 247.0 |
| Accrued pension and postretirement benefits | 51.9 | 69.6 |
| Long-term deferred tax liability | 38.2 | 34.8 |
| Other liabilities | 98.4 | 106.1 |
| Total liabilities | 580.5 | 1,000.9 |
| Commitments and contingencies (Note 12) | ||
| Equity: | ||
| Common shares, par value $1.00; 66,475,307 shares authorized; 57,593,476 and 57,290,198 shares issued and outstanding, respectively | 57.6 | 57.3 |
| Capital surplus | 447.6 | 425.5 |
| Retained earnings | 1,463.0 | 1,217.8 |
| Accumulated other comprehensive loss | (2.0) | (61.9) |
| Total shareholders’ equity | 1,966.2 | 1,638.7 |
| Noncontrolling interests | 2.3 | 2.3 |
| Total equity | 1,968.5 | 1,641.0 |
| Total liabilities and equity | $2,549.0 | $2,641.9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.